The fusion of agency and consultancy Healthware into global agency network Eversana Intouch is complete, parent company Eversana said Monday.
Healthware, headquartered in Salerno, Italy, will operate under the name Eversana Intouch Healthware, serving clients from offices around the world. Fulvio Fortini, SVP and MD, was appointed as head of the firm.
As previously announced, Healthware’s founder, Roberto Ascione, assumed a larger role leading health innovation initiatives across Eversana.
“More than ever, our clients need partners with global strategy and integrated commercial solutions to bring brands to life around the world,” Eversana CEO Jim Lang noted in a statement. “Now, through the expanded full-service affiliate of Eversana Intouch Healthware and coupled with Roberto’s new role driving greater innovation and transformation for clients, we’re positioned to deliver greater value to clients and their brands than ever before.”
Innovative strategies are “paramount” at a time when brands are challenged to meet diverse patient needs, added Ascione, president, health innovation for Eversana.
“We are excited to harness our expertise to deliver customized, technology-driven solutions that effectively tackle the unique challenges confronting our clients in this ever-evolving landscape,” he stated.
Healthware was snapped up by the PE-backed agency network last October. The purchase came roughly two years after the 2023 MM+M Agency 100 honoree’s acquisition of Intouch Solutions brought the full gamut of commercial services under one roof.
Healthware brought with it 150 staff and an expanded set of commercialization services ranging from expertise in advisory and customer engagement to med comms and media services, branding and creative. Eversana also became the owner of Healthware’s Frontiers Health conference and pharma news outlet Pharmaphorum.
Eversana’s sixth full-service affiliate, Healthware already had an existing partnership with the company dating to 2017. Outside of Italy, Healthware’s offices include Finland, the United Kingdom and the United States.
Also on the European front, in December Eversana united a global alliance of seven pharma commercialization firms from various countries. The Global Alliance for Pharma Solutions (GAPS), of which Eversana is a founding member, was formed last July.
According to the MM+M Agency 100 2023 revenue chart, Eversana saw a 20% increase in revenue from $325 million in 2021 to $390 million in 2022.
